Neuroendocrine differentiation in carcinoma of the breast: Tyramide signal amplification discloses chromogranin A-positive tumour cells in more breast tumours than previously realized

APMIS

Volumn 110, Issue 9, 2002, Pages 658-664

  Bofin, A M ^a,b   Qvigstad, G ^b   Waldum, C ^b   Waldum, H L ^b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Breast carcinomas; Chromogranin A; Neuroendocrine differentiation; Tyramide signal amplification

Indexed keywords

CHROMOGRANIN A; ESTROGEN RECEPTOR; ISOPROPAMIDE IODIDE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CARCINOMA; CANCER GRADING; CARCINOMA IN SITU; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROSECRETORY CELL; ONCOGENE NEU; PRIORITY JOURNAL; SIGNAL PROCESSING; TECHNIQUE;

ADENOCARCINOMA, MUCINOUS; ANTIBODIES; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; CARCINOMA, NEUROENDOCRINE; CELL DIFFERENTIATION; CHROMOGRANIN A; CHROMOGRANINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; TYRAMINE;

EID: 0036757227     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2002.1100910.x     Document Type: Article

References (24)

1. Feyrter F, Hartmann G. Über die carcinoide Wuchsform des carcinoma mammae, insbesondere das carcinoma solidum (gelatinosum) mammae. Frankf Z Pathol 1963;73:24-39.
2. Cubilla AL, Woodruff JM. Primary carcinoid tumour of the breast. A report of eight cases. Am J Surg Pathol 1977;1:283-92.
3. Ferguson DJP, Anderson TJ. Distribution of dense core granules in normal, benign and malignant breast tissue. J Pathol 1985;147:59-65.
4. Clayton F, Ordonez NG, Sibley RK, Hanssen G. Argyrophilic breast carcinomas: Evidence of lactational differentiation. Am J Surg Pathol 1982; 6:323-33.
5. Bussolati G, Gugliotta P, Sapino A, Eusebi V, Lloyd RV. Chromogranin-reactive endocrine cells in argyophilic carcinomas ("carcinoids") and normal tissue of the breast. Am J Pathol 1985; 120:186-92.
6. Partanen S, Syrjänen K. Argyrophilic cells in carcinoma of the female breast. Virchows Arch 1981;391:45-51.
7. Capella C, Eusebi V, Mann B, Azzopardi JG. Endocrine differentiation in mucoid carcinoma of the breast. Histopathology 1980;4:613-30.
8. Coombes RC, Easty GC, Detre SI, Hillyard CJ, Stevens U, Girgis SI, Galante LS, Heywood L, Macintyre I, Neville AM. Secretion of immunoreactive calcitonin by human breast carcinomas. Br Med J 1975;4:197-9.
9. Kaneko H, Hojo H, Ishikawa S, Yamanouchi H, Sumida T, Saito R. Norepinephrine-producing tumors of bilateral breasts. Cancer 1978;41: 2002-7.
10. Bussolati G, Papotti M, Sapino A, Gugliotta P, Ghiringhello B, Azzopardi JG. Endocrine markers in argyrophilic carcinomas of the breast. Am J Surg Pathol 1987;11:248-56.
11. Pagani A, Papotti M, Höfler H, Weiler R, Winkler H, Bussolati G. Chromogranin A and B gene expression in carcinomas of the breast. Am J Pathol 1990;136:319-27.
12. Nesland JM, Holm R, Johannessen JV. A study of different markers for neuroendocrine differentiation in breast carcinomas. Pathol Res Pract 1986;181:524-30.
13. Nesland JM, Memoli VA, Holm R, Gould VE, Johannessen JV. Breast carcinomas with neuroendocrine differentiation. Ultrastruct Pathol 1985; 8:225-40.
14. Scopsi L, Andreola S, Pilotti S, Bufalino R, Baldini MT, Testori A, Rilke F. Mucinous carcinoma of the breast. A clinicopathologic, histochemical, and immunocytochemical study with special reference to neuroendocrine differentiation. Am J Surg Pathol 1994;18:702-11.
15. Pagani A, Papotti M, Sanfilippo B, Bussolati G. Expression of the gastrin-releasing peptide gene in carcinomas of the breast. Int J Cancer 1991; 47:371-5.
16. Scopsi L, Andreola S, Pilotti S, Testori A, Baldini MT, Leoni F, Lombardi L, Hutton JC, Shimizu F, Rosa P, Huttner WB, Rilke F. Argyrophilia and granin (chromogranin/secretogranin) expression in female breast carcinomas. Their relationship to survival and other disease parameters. Am J Surg Pathol 1992;16:561-76.
17. Tsang WYW, Chan JKC. Endocrine ductal carcinoma in situ (E-DCIS) of the breast. Am J Surg Pathol 1996;20:921-43.
18. Soriano JV, Pepper MS, Taupenot L, Bader MF, Orci L, Montesano R. Chromogranin A alters ductal morphogenesis and increases deposition of basement membrane components by mammary epithelial cells in vitro. Biochem Biophys Res Commun 1999;259:563-8.
19. Qvigstad G, Sandvik AK, Brenna E, Aase S, Waldum HL. Detection of chromogranin A in human gastric adenocarcinomas using a sensitive immunohistochemical technique. Histochem J 2000;32:551-6.
20. Waldum HL, Aase S, Kvetnoi I, Brenna, E, Sandvik AK, Syversen U, et al. Neuroendocrine differentiation in human gastric carcinomas. Cancer 1998;83:435-44.
21. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957;11:359-77.
22. Erikstein B, Nesland JM, Ottestad L, Lund E, Johannessen JV. Neuron specific enolase-positive breast carcinomas. Histol Histopathol 1988;3: 97-102.
23. von Wasielewski R, Mengel M, Gignac S, Wilkens L, Werner M, Georgii A. Tyramine amplification technique in routine immunohistochemistry. J Histochem Cytochem 1997;45:1455-9.
24. Mengel M, Werner M, von Wasielewski R. Concentration dependent and adverse effects in immunohistochemistry using the tyramine amplification technique. Histochem J 1999;31:195-200.